Erbitux Hearing Suggests Need To Revisit Fast Track Process – Rep. Burr

The Erbitux development problems suggest that the Fast Track process may not be working as well as expected, Rep. Richard Burr (R-N.C.) said during a June 13 Energy & Commerce/Oversight Subcommittee hearing on the ImClone/Bristol oncologic agent